Labcyte wins $1M award for protein biomarker research; Investigators outline Roche drug's impact on macular degeneration;

> The NCI has awarded Labcyte $1 million to work on new technology for evaluating protein biomarkers for cancer, beginning with a focus on breast cancer. Story (reg. req.)

> Investigators have been spelling out the effect of Roche's ($RHHBY) lampalizumab on a biomarker-defined subset of patients with macular degeneration. Report (reg. req.)

Suggested Articles

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.

Sensyne Health aims to bring its AI tools to America, and it’s enlisting IT giant Cognizant and data infrastructure specialist Agorai to help.

Daré Bioscience added a microchip-based implant to its pipeline and reported data from a pre-pivotal study of a hormone-free contraceptive ring.